Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients
- PMID: 18243664
- PMCID: PMC2746974
- DOI: 10.1016/j.schres.2007.12.474
Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients
Abstract
Neuregulin-1 (NRG1) and its receptor, ErbB4, have been implicated in schizophrenia at both gene and transcript levels. The present investigation compared NRG1 and ErbB4 protein levels in prefrontal cortical (PFC) cytoplasmic and nuclear fractions among normal, schizophrenic, bipolar and major depressed subjects from the Stanley Consortium. We used immunoblotting procedures to examine potential NRG1 and ErbB4 immunoreactive bands, but specifically quantified NRG1 immunoreactive signals at 42, 48 and 53 kDa and ErbB4 immunoreactive signals at 21, 55, 60 and 180 kDa. PFC cytoplasmic 53 kDa NRG1 protein levels were significantly increased (approximately 20%) in schizophrenic patients relative to each of the other subject groups. We also detected diagnostic effects on PFC cytoplasmic full-length (180 kDa) ErbB4 protein levels, and post hoc tests revealed that these quantities were significantly increased (approximately 30%) in schizophrenic patients relative to normal and to depressed subjects. In addition, we examined the levels of potential ErbB4 cleavage products at 21, 55 and 60 kDa relative to those of full-length ErbB4 in the PFC fractions. We detected trends for diagnostic effects on PFC cytoplasmic 21 kDa/180 kDa and 55 kDa/180 kDa ratios, and post hoc tests revealed that these ratios were significantly reduced in schizophrenic patients relative to normal individuals. Our investigation suggests that schizophrenia-associated NRG1 and ErbB4 mRNA elevations also occur at the protein level and may be specific to schizophrenia. We hypothesize that ErbB4 proteolytic processing may also be altered in schizophrenia, yielding altered ratios of functionally distinct forms of ErbB4.
Figures
Similar articles
-
Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain.Psychiatry Res. 2015 Feb 28;225(3):347-54. doi: 10.1016/j.psychres.2014.12.014. Epub 2014 Dec 19. Psychiatry Res. 2015. PMID: 25576368
-
Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.Arch Gen Psychiatry. 2010 Oct;67(10):991-1001. doi: 10.1001/archgenpsychiatry.2010.117. Arch Gen Psychiatry. 2010. PMID: 20921115 Free PMC article.
-
Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2006 Jan 5;141B(1):96-101. doi: 10.1002/ajmg.b.30236. Am J Med Genet B Neuropsychiatr Genet. 2006. PMID: 16249994
-
Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.Psychopharmacology (Berl). 2013 Mar;226(2):201-15. doi: 10.1007/s00213-013-3003-2. Epub 2013 Feb 7. Psychopharmacology (Berl). 2013. PMID: 23389757 Review.
-
Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.Nat Rev Neurosci. 2008 Jun;9(6):437-52. doi: 10.1038/nrn2392. Epub 2008 May 14. Nat Rev Neurosci. 2008. PMID: 18478032 Free PMC article. Review.
Cited by
-
Neuregulin repellent signaling via ErbB4 restricts GABAergic interneurons to migratory paths from ganglionic eminence to cortical destinations.Neural Dev. 2012 Feb 29;7:10. doi: 10.1186/1749-8104-7-10. Neural Dev. 2012. PMID: 22376909 Free PMC article.
-
Advantages and Limitations of Animal Schizophrenia Models.Int J Mol Sci. 2022 May 25;23(11):5968. doi: 10.3390/ijms23115968. Int J Mol Sci. 2022. PMID: 35682647 Free PMC article. Review.
-
Transcriptome Profiling Reveals Novel Candidate Genes Related to Hippocampal Dysfunction in SREBP-1c Knockout Mice.Int J Mol Sci. 2020 Jun 10;21(11):4131. doi: 10.3390/ijms21114131. Int J Mol Sci. 2020. PMID: 32531902 Free PMC article.
-
Interneuronal DISC1 regulates NRG1-ErbB4 signalling and excitatory-inhibitory synapse formation in the mature cortex.Nat Commun. 2015 Dec 11;6:10118. doi: 10.1038/ncomms10118. Nat Commun. 2015. PMID: 26656849 Free PMC article.
-
ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors.Mol Psychiatry. 2018 Nov;23(11):2227-2237. doi: 10.1038/mp.2017.132. Epub 2017 Jul 20. Mol Psychiatry. 2018. PMID: 28727685 Free PMC article.
References
-
- Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney WE, Jr, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry. 1996;53:425–436. - PubMed
-
- Anton ES, Ghashghaei HT, Weber JL, McCann C, Fischer TM, Cheung ID, Gassmann M, Messing A, Klein R, Schwab MH, Lloyd KC, Lai C. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci. 2004;7:1319–1328. - PubMed
-
- Bao J, Lin H, Ouyang Y, Lei D, Osman A, Kim TW, Mei L, Dai P, Ohlemiller KK, Ambron RT. Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos. Nat Neurosci. 2004;7:1250–1258. - PubMed
-
- Bertram I, Bernstein HG, Lendeckel U, Bukowska A, Dobrowolny H, Keilhoff G, Kanakis D, Mawrin C, Bielau H, Falkai P, Bogerts B. Immunohistochemical evidence for impaired neuregulin-1 signaling in the prefrontal cortex in schizophrenia and in unipolar depression. Ann N Y Acad Sci. 2007;1096:147–156. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
